These shares have made their shareholders wealthy over the past year. The post Why 4DMedical and these ASX shares are up ...

Innovative Trial Design to Directly Measure Microvascular Functional Effects of Inhaled Therapy at the Capillary level of ...

DMedical, the leader in software-based respiratory imaging technology, today announced US$100+ million (AU$150 million) in ...

Lung imaging house 4D Medical this week is finalising its monster $150 million fund raising for a "once in a generation" US ...

After a transformative run of regulatory wins and commercial deals, the company has secured the backing of major investors in ...

The $2.3b market darling is expected to raise $150m after an extraordinary 5-month share price surge, but investors are split ...

Findings Show Xenon MRI Ventilation Defects Independently Predicts Exacerbation Risk Beyond Conventional Clinical Measures ...

D Medical (ASX: 4DX) inks UC San Diego Health as its 4th US centre to use CT:VQ, with launch pricing ahead of broader commercial rollout.

ABSTRACT: Pregnancy and peripartum period leads to Virchow’s triad (hypercoagulability, venous stasis and vascular injury) thereby increasing the risk of thromboembolism by many folds in these ...

A cross-disciplinary research team has, for the first time, successfully applied NIR-II (1,000–3,000 nm) fluorescence video imaging during esophagectomy—a complex surgical procedure involving the ...

Evaluation for pulmonary hypertension (PH) in patients with cancer must include either lung ventilation/perfusion scan or dual-energy computed tomography of the chest to evaluate for acute and/or ...